Kissei Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd. is a Private limited company (Ltd.) registered in Japan under 1100001012982, and its current status with National Tax Agency — Corporate Number Publication Site is active. The company was incorporated on 5 October 2015 and lists its registered address as Matsumoto City, Japan. 5 shareholders are on record for Kissei Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from National Tax Agency — Corporate Number Publication Site and was last updated on 2 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Kissei Pharmaceutical Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing.
The largest of these is Vanguard Whitehall Funds-International Explorer Fund, holding 9.5% — the largest recorded stake — followed by Vanguard International Stock Index-Total Intl Stock Indx at 8.7%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 9 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Whitehall Funds-International Explorer Fund | 9.5% | National Tax Agency — Corporate Number Publication Site | |
| Vanguard International Stock Index-Total Intl Stock Indx | 8.7% | National Tax Agency — Corporate Number Publication Site | |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 5.4% | National Tax Agency — Corporate Number Publication Site | |
| Hartford International Value Fund | 5.3% | National Tax Agency — Corporate Number Publication Site | |
| Brandes International Small Cap Equity Fund | 4.7% | National Tax Agency — Corporate Number Publication Site |
Officers
5
The Executive Md & Director of Kissei Pharmaceutical Co., Ltd. currently on record is Tetsu Takayama; five officers are currently on record for Kissei Pharmaceutical Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site.
The register reports 8 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Kissei Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Kissei Pharmaceutical Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 3 subsidiaries span Japan jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Kissei Pharmaceutical Co., Ltd.
Japan
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Kissei Pharmaceutical Co., Ltd.?
Five shareholders are currently on record for Kissei Pharmaceutical Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is Vanguard Whitehall Funds-International Explorer Fund, holding 9.5% — the largest recorded stake — followed by Vanguard International Stock Index-Total Intl Stock Indx at 8.7%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Kissei Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Kissei Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Kissei Pharmaceutical Co., Ltd. have on record?
5 shareholders are shown on record for Kissei Pharmaceutical Co., Ltd.. The register reports 9 in total; only the top 5 by holding are shown here.
What is Kissei Pharmaceutical Co., Ltd.'s company registration number?
Kissei Pharmaceutical Co., Ltd.'s registration number is 1100001012982, filed with National Tax Agency — Corporate Number Publication Site in Japan. Its current status on the register is active.
Is Kissei Pharmaceutical Co., Ltd. still an active company?
Kissei Pharmaceutical Co., Ltd.'s status on National Tax Agency — Corporate Number Publication Site is listed as active.
When was Kissei Pharmaceutical Co., Ltd. incorporated?
Kissei Pharmaceutical Co., Ltd. was incorporated on 5 October 2015, according to National Tax Agency — Corporate Number Publication Site.
What is Kissei Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Kissei Pharmaceutical Co., Ltd. is Matsumoto City, Japan.
What legal structure is Kissei Pharmaceutical Co., Ltd. registered as?
Kissei Pharmaceutical Co., Ltd. is registered as a Private limited company (Ltd.) in Japan.
Who are the officers/directors of Kissei Pharmaceutical Co., Ltd.?
The Executive Md & Director of Kissei Pharmaceutical Co., Ltd. currently on record is Tetsu Takayama; five officers are currently on record for Kissei Pharmaceutical Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Management authority at Kissei Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Kissei Pharmaceutical Co., Ltd. have a parent company or subsidiaries?
Kissei Pharmaceutical Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 1 jurisdiction. Those 3 subsidiaries span Japan jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Kissei Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from National Tax Agency — Corporate Number Publication Site. Zavia's monitoring API can track changes to Kissei Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Kissei Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Japan, so records like Kissei Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from National Tax Agency — Corporate Number Publication Site and was last synced on 2 October 2026.